The Northern Health Science Alliance (NHSA) and MedCity have partnered together to foster economic growth and speed up the development of health innovations to the public in the North of England by linking academia, the NHS and companies across the UK’s life sciences industry.
Beside promoting life sciences in their respective regions, the organisations will also focus on building relationships with countries, such as Japan, Israel or China to raise the UK's profile in these markets.
The project, funded by Research by Research England, will also help meet Grand Hhallenges of the Industrial Strategy, especially in AI and data, healthy ageing, genomics and advanced therapies.
Dr Seamus O’Neill, Chief Executive at NHSA, said: “We’re delighted to be awarded funding from Research England. This collaboration with MedCity provides a real opportunity to build on our collective work to support and maintain a strong and vibrant life sciences sector in the UK.
“We have clear and defined aims to drive this work forward using the funding, with a focus on strengthening links across the life science clusters in the UK, delivering against the Industrial Strategy and championing the UK’s life sciences offer internationally to attract investment into the sector.”
Neelam Patel, Chief Executive at MedCity, commented: “The UK life sciences sector is at a pivotal moment in its development, with exceptional governmental support in the form of the Industrial Strategy and a high level of interest from abroad in its academic, clinical and industrial excellence. Against this backdrop and to meet any challenge that might arise from Brexit, it is vital that we create the right conditions for the UK life sciences sector to grow and deliver its potential."
To read more, please click here.